FDA Dispute Resolution Committees Will Be Center-Based, Final Rule States
This article was originally published in The Gray Sheet
Executive Summary
FDA will not establish separate procedures for requesting review of scientific controversies under Sec. 404 of the FDA Modernization Act, the agency maintains in its "Administrative Practices and Procedures; Internal Review of Decisions" final rule, published in the Nov. 18 Federal Register.